Business Context and Reporting Period
This Form 8-K is a current report filed by Capricor Therapeutics, Inc. on January 13, 2014. The filing serves as a Regulation FD disclosure regarding upcoming presentations by the company's Chief Executive Officer, Dr. Linda Marbán, at the JP Morgan Conference scheduled between January 13, 2014, and January 16, 2014, in the San Francisco area.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly informational regarding a corporate event and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces the availability of presentation slides related to the upcoming conference.
Guidance, Outlook, and Management Commentary
- Management Commentary: Dr. Linda Marbán, CEO, will present slides at various meetings during the JP Morgan Conference.
- Availability of Information: A copy of the presentation slides is available on the "Investors" section of the Company's website and will be archived for at least 30 days.
- Legal Disclaimer: The information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the presentation slides posted on the company's investor website.
- Confirm the specific dates and times of Dr. Marbán's presentations at the JP Morgan Conference.
- Note that this filing does not contain new financial data or operational results.